Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer
Sponsor: Chang Gung Memorial Hospital
Summary
This is a prospective, single-center, single arm, open label study to evaluate the performance of 68Ga-FAPI-46 for the diagnosis of primary and metastatic lesions of lung cancer with comparison to 18F-FDG PET.
Official title: 68Ga-FAPI PET in Evaluation of the Patient With Known or Suspected Lung Cancer: Comparison With Standard 18F-FDG PET
Key Details
Gender
All
Age Range
20 Years - Any
Study Type
INTERVENTIONAL
Enrollment
58
Start Date
2022-12-01
Completion Date
2026-01-31
Last Updated
2026-05-13
Healthy Volunteers
No
Conditions
Interventions
68Ga-FAPI-46
68Ga-FAPI-46 is a radioactive diagnostic agent for PET imaging in the detection of Fibroblast Activation Protein (FAP) positive tumor cells in cancer patients
Locations (1)
Department of Nuclear Medicine, Chang Gung Memorial Hospital
Taoyuan, Taiwan